drugset / Trial / NCT00193908

Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream

NCT00193908 ↗

Phase 3 Completed 333 enrolled Trans Tasman Radiation Oncology Group 3M · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study has patients using two different moisturising creams during radiation therapy after mastectomy. These are Cavilon and sorbolene. It is hypothesised that skin reactions may be reduced by the Cavilon cream compared to sorbolene.

Timeline

Start
2004-03
Primary completion
2007-09
Completion
2008-10

Outcome

Missed primary endpoint

paper There was no significant difference between MDBC and sorbolene in the primary endpoint of peak skin reactions PMID 23414763 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Cavilon (TM) Durable Barrier Cream Unknown — Topical
Subject Sorbolene Unknown — Topical

Indications